A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II

标题
A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II
作者
关键词
mucopolysaccharidosis II, Hunter syndrome, pabinafusp alfa, blood brain barrier, iduronate-2-sulfatase, central nervous system, neurocognitive development, neurocognitive impairment, neurodegeneration, anti-human transferrin receptor antibody, heparan sulfate, enzyme-replacement therapy
出版物
MOLECULAR THERAPY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2020-09-30
DOI
10.1016/j.ymthe.2020.09.039

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started